Literature DB >> 30999272

Multiple distinct O-Mannosylation pathways in eukaryotes.

Ida Signe Bohse Larsen1, Yoshiki Narimatsu1, Henrik Clausen1, Hiren J Joshi2, Adnan Halim3.   

Abstract

Protein O-mannosylation (O-Man), originally discovered in yeast five decades ago, is an important post-translational modification (PTM) conserved from bacteria to humans, but not found in plants or nematodes. Until recently, the homologous family of ER-located protein O-mannosyl transferases (PMT1-7 in yeast; POMT1/POMT2 in humans), were the only known enzymes involved in directing O-Man biosynthesis in eukaryotes. However, recent studies demonstrate the existence of multiple distinct O-Man glycosylation pathways indicating that the genetic and biosynthetic regulation of O-Man in eukaryotes is more complex than previously envisioned. Introduction of sensitive glycoproteomics strategies provided an expansion of O-Man glycoproteomes in eukaryotes (yeast and mammalian cell lines) leading to the discovery of O-Man glycosylation on important mammalian cell adhesion (cadherin superfamily) and signaling (plexin family) macromolecules, and to the discovery of unique nucleocytoplasmic O-Man glycosylation in yeast. It is now evident that eukaryotes have multiple distinct O-Man glycosylation pathways including: i) the classical PMT1-7 and POMT1/POMT2 pathway conserved in all eukaryotes apart from plants; ii) a yet uncharacterized nucleocytoplasmic pathway only found in yeast; iii) an ER-located pathway directed by the TMTC1-4 genes found in metazoans and protists and primarily dedicated to the cadherin superfamily; and iv) a yet uncharacterized pathway found in metazoans primarily dedicated to plexins. O-Man glycosylation is thus emerging as a much more widespread and evolutionary diverse PTM with complex genetic and biosynthetic regulation. While deficiencies in the POMT1/POMT2 O-Man pathway underlie muscular dystrophies, the TMTC1-4 pathway appear to be involved in distinct congenital disorders with neurodevelopmental phenotypes. Here, we review and discuss the recent discoveries of the new non-classical O-Man glycosylation pathways, their substrates, functions and roles in disease.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30999272     DOI: 10.1016/j.sbi.2019.03.003

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  12 in total

Review 1.  Pathway engineering facilitates efficient protein expression in Pichia pastoris.

Authors:  Chao Liu; Jin-Song Gong; Chang Su; Hui Li; Heng Li; Zhi-Ming Rao; Zheng-Hong Xu; Jin-Song Shi
Journal:  Appl Microbiol Biotechnol       Date:  2022-08-30       Impact factor: 5.560

2.  Contrasting the conformational effects of α-O-GalNAc and α-O-Man glycan protein modifications and their impact on the mucin-like region of alpha-dystroglycan.

Authors:  Andrew Borgert; B Lachele Foley; David Live
Journal:  Glycobiology       Date:  2021-06-03       Impact factor: 4.313

3.  Circadian clock control of eIF2α phosphorylation is necessary for rhythmic translation initiation.

Authors:  Shanta Karki; Kathrina Castillo; Zhaolan Ding; Olivia Kerr; Teresa M Lamb; Cheng Wu; Matthew S Sachs; Deborah Bell-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-30       Impact factor: 11.205

4.  Endoplasmic reticulum transmembrane protein TMTC3 contributes to O-mannosylation of E-cadherin, cellular adherence, and embryonic gastrulation.

Authors:  Jill B Graham; Johan C Sunryd; Ketan Mathavan; Emma Weir; Ida Signe Bohse Larsen; Adnan Halim; Henrik Clausen; Hélène Cousin; Dominque Alfandari; Daniel N Hebert
Journal:  Mol Biol Cell       Date:  2019-12-18       Impact factor: 4.138

5.  Conserved sequence motifs in human TMTC1, TMTC2, TMTC3, and TMTC4, new O-mannosyltransferases from the GT-C/PMT clan, are rationalized as ligand binding sites.

Authors:  Birgit Eisenhaber; Swati Sinha; Chaitanya K Jadalanki; Vladimir A Shitov; Qiao Wen Tan; Fernanda L Sirota; Frank Eisenhaber
Journal:  Biol Direct       Date:  2021-01-12       Impact factor: 4.540

6.  Functional implications of MIR domains in protein O-mannosylation.

Authors:  Antonella Chiapparino; Antonija Grbavac; Hendrik Ra Jonker; Yvonne Hackmann; Sofia Mortensen; Ewa Zatorska; Andrea Schott; Gunter Stier; Krishna Saxena; Klemens Wild; Harald Schwalbe; Sabine Strahl; Irmgard Sinning
Journal:  Elife       Date:  2020-12-24       Impact factor: 8.140

7.  Mammalian brain glycoproteins exhibit diminished glycan complexity compared to other tissues.

Authors:  Sarah E Williams; Maxence Noel; Sylvain Lehoux; Murat Cetinbas; Ramnik J Xavier; Ruslan I Sadreyev; Edward M Scolnick; Jordan W Smoller; Richard D Cummings; Robert G Mealer
Journal:  Nat Commun       Date:  2022-01-12       Impact factor: 17.694

8.  On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape.

Authors:  Stacy Alyse Malaker; Jusal Quanico; Antonella Raffo-Romero; Firas Kobeissy; Soulaimane Aboulouard; Dominique Tierny; Carolyn Ruth Bertozzi; Isabelle Fournier; Michel Salzet
Journal:  Cell Chem Biol       Date:  2021-06-07       Impact factor: 8.116

Review 9.  Meta-heterogeneity: Evaluating and Describing the Diversity in Glycosylation Between Sites on the Same Glycoprotein.

Authors:  Tomislav Čaval; Albert J R Heck; Karli R Reiding
Journal:  Mol Cell Proteomics       Date:  2020-12-08       Impact factor: 5.911

Review 10.  Glycomics, Glycoproteomics, and Glycogenomics: An Inter-Taxa Evolutionary Perspective.

Authors:  Christopher M West; Daniel Malzl; Alba Hykollari; Iain B H Wilson
Journal:  Mol Cell Proteomics       Date:  2021-01-06       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.